跳至主要内容
临床试验/NCT00368641
NCT00368641终止2 期

Treatment-Resistant Heart Failure (HF) and Peritoneal Ultrafiltration (PUF): A Randomized Prospective Trial of Standard Care Versus Standard Care With Peritoneal Ultrafiltration in Patients With Treatment-Resistant Severe Heart Failure

Vantive Health LLC0 个研究点目标入组 12 人开始时间: 2006年8月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
终止
入组人数
12
主要终点
All-cause Hospitalization (Unadjusted)

研究概览

简要总结

The objective of the study is to determine if the addition of peritoneal ultrafiltration to standard therapy in treatment-resistant severe heart failure patients will improve fluid balance and functional capacity such that they will spend less time in the hospital and have an improved ambulatory quality of life in comparison to patients who remain on standard therapy alone.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults with congestive heart failure (CHF) who remain fluid overloaded despite standard treatment.

排除标准

  • Patients who have reversible CHF or have diseases or conditions that would contraindicate the use of peritoneal dialysis.

研究组 & 干预措施

Intervention

Experimental

peritoneal dialysis

干预措施: Extraneal (Drug)

结局指标

主要结局

All-cause Hospitalization (Unadjusted)

时间窗: 6 to 24 months

All-cause hospitalization was defined as (1) hospitalization for any cause of any duration or (2)any ER visit or any clinic visit specifically for congestive heart failure requiring intravenous administration of an inotrope, vasodilator or diuretic.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

Heart Failure and Peritoneal Ultrafiltration | 临床试验